Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-027583

BIOLASE, INC · BIOL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul N Clark
Director
Period of report
Apr 18, 2017
Accepted (ET)
Apr 19, 2017 · 7:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series D Participating Convertible Preferred StockF1,F3,F4,F2—Apr 18, 2017P1,536A——Common Stock156,3001,536I
Warrants (right to buy)F3,F4$1.80Apr 18, 2017P76,089AOct 18, 2017Apr 18, 2022Common Stock76,08976,089I

Explanation of responses